Network pharmacology based high throughput screening for identification of multi targeted anti-diabetic compound from traditionally used plants

References

• Alam, S., & Khan, F. (2018). Virtual screening, Docking, ADMET and System Pharmacology studies on Garcinia caged Xanthone derivatives for Anticancer activity. Scientific Reports, 8(1), 1–16. https://doi.org/10.1038/s41598-018-23768-7
   PubMed Web of Science ®Google Scholar
• Amirkia, V., & Heinrich, M. (2015). Natural products and drug discovery: A survey of stakeholders in industry and academia. Frontiers in Pharmacology, 6, 237–238. https://doi.org/10.3389/fphar.2015.00237
   PubMed Web of Science ®Google Scholar
• Arooj, M., Thangapandian, S., John, S., Hwang, S., Park, J. K., & Lee, K. W. (2011). 3D QSAR pharmacophore modeling, in silico screening, and density functional theory (DFT) approaches for identification of human chymase inhibitors. International Journal of Molecular Sciences, 12(12), 9236–9264. https://doi.org/10.3390/ijms12129236
   PubMed Web of Science ®Google Scholar
• Bailey, C. J. & Day, D. (2003). Antidiabetic drugs. The British Journal of Cardiology, 10, 128–136. https://bjcardio.co.uk/2003/03/antidiabetic-drugs/
   Google Scholar
• Bastikar, V. A., Bastikar, A. V., & Chhajed, S. S. (2020). Understanding the role of natural medicinal compounds such as curcumin and allicin against SARS-CoV-2 proteins as potential treatment against COVID-19: An in silico approach. Journal of Proteomics & Bioinformatics, 13(7), 1–14. https://doi.org/10.35248/0974-276X.1000510
   Google Scholar
• Biggadike, K., Bledsoe, R. K., Coe, D. M., Cooper, T. W. J., House, D., Iannone, M. A., Macdonald, S. J. F., Madauss, K. P., McLay, I. M., Shipley, T. J., Taylor, S. J., Tran, T. B., Uings, I. J., Weller, V., & Williams, S. P. (2009). Design and x-ray crystal structures of high-potency nonsteroidal glucocorticoid agonists exploiting a novel binding site on the receptor. Proceedings of the National Academy of Sciences of the United States of America, 106(43), 18114–18119. https://doi.org/10.1073/pnas.0909125106
   PubMed Web of Science ®Google Scholar
• Chen, C., Wang, T., Wu, F., He, G., Ouyang, L., Xiang, M., Jiang, Q., Huang, W., & Peng, C. (2014). Combining structure-based pharmacophore modeling, virtual screening, and in silico ADMET analysis to discover novel tetrahydro-quinoline based pyruvate kinase isozyme M2 activators with antitumor activity. Drug Design, Development and Therapy, 8, 1195–1210. https://doi.org/10.2147/DDDT.S62921
   PubMed Web of Science ®Google Scholar
• Cronet, P., Petersen, J. F. W., Folmer, R., Blomberg, N., Sjöblom, K., Karlsson, U., Lindstedt, E. L., & Bamberg, K. (2001). Structure of the PPARα and -γ ligand binding domain in complex with AZ 242; ligand selectivity and agonist activation in the PPAR family. Structure (London, England : 1993), 9(8), 699–706. (01)00634-7 https://doi.org/10.1016/S0969-2126(01)00634-7
   PubMed Web of Science ®Google Scholar
• Dajani, R., Fraser, E., Roe, S. M., Young, N., Good, V., Dale, T. C., & Pearl, L. H. (2001). Crystal structure of glycogen synthase kinase 3β: Structural basis for phosphate-primed substrate specificity and autoinhibition. Cell, 105(6), 721–732. (01)00374-9 https://doi.org/10.1016/S0092-8674(01)00374-9
   PubMed Web of Science ®Google Scholar
• Diabetes (2020). World Health Organization. https://www.who.int/news-room/fact-sheets/detail/diabetes
   Google Scholar
• Einstein, M., Akiyama, T. E., Castriota, G. A., Wang, C. F., McKeever, B., Mosley, R. T., Becker, J. W., Moller, D. E., Meinke, P. T., Wood, H. B., & Berger, J. P. (2008). The differential interactions of peroxisome proliferator-activated receptor gamma ligands with Tyr473 is a physical basis for their unique biological activities. Molecular Pharmacology, 73(1), 62–74. https://doi.org/10.1124/mol.107.041202
   PubMed Web of Science ®Google Scholar
• Favelyukis, S., Till, J. H., Hubbard, S. R., & Miller, W. T. (2001). Structure and autoregulation of the insulin-like growth factor 1 receptor kinase. Nature Structural Biology, 8(12), 1058–1063. https://doi.org/10.1038/nsb721
   PubMedGoogle Scholar
• Global Report on Diabetes WHO Library Cataloguing-in-Publication Data Global report on diabetes (2016). http://www.who.int/about/licensing/copyright_form/index.html
   Google Scholar
• Gogoi, B., Gogoi, D., Silla, Y., Kakoti, B. B., & Bhau, B. S. (2017). Network pharmacology-based virtual screening of natural products from Clerodendrum species for identification of novel anti-cancer therapeutics. Molecular bioSystems, 13(2), 406–416. https://doi.org/10.1039/c6mb00807k
   PubMedGoogle Scholar
• Gogoi, D., Baruah, V. J., Chaliha, A. K., Kakoti, B. B., Sarma, D., & Buragohain, A. K. (2016). 3D pharmacophore-based virtual screening, docking and density functional theory approach towards the discovery of novel human epidermal growth factor receptor-2 (HER2) inhibitors. Journal of Theoretical Biology, 411, 68–80. https://doi.org/10.1016/j.jtbi.2016.09.016
   PubMed Web of Science ®Google Scholar
• Gogoi, D., Chaliha, A. K., Sarma, D., Kakoti, B. B., & Buragohain, A. K. (2017). Novel butyrylcholinesterase inhibitors through pharmacophore modeling, virtual screening and DFT-based approaches along-with design of bioisosterism-based analogues. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, 85, 646–657. https://doi.org/10.1016/j.biopha.2016.11.076
   PubMed Web of Science ®Google Scholar
• Gogoi, N., Chetia, D., Gogoi, B., & Das, A. (2021). Multiple-targets directed screening of flavonoid compounds from Citrus species to find out antimalarial lead with predicted mode of action: An in silico and whole cell-based in vitro approach. Current Computer-Aided Drug Design, 17(1), 69–82. https://doi.org/10.2174/1573409916666191226103000
   PubMed Web of Science ®Google Scholar
• Gu, J., Gui, Y., Chen, L., Yuan, G., Lu, H. Z., & Xu, X. (2013). Use of Natural Products as Chemical Library for Drug Discovery and Network Pharmacology. PLoS One, 8(4), e62839–10. https://doi.org/10.1371/journal.pone.0062839
   PubMed Web of Science ®Google Scholar
• Guo, Y. B., Liang, Y. C., Chen, M. J., Bai, Q. S., & Lu, L. H. (2010). Molecular dynamics simulations of thermal effects in nanometric cutting process. Science China Technological Sciences, 53(3), 870–874. https://doi.org/10.1007/s11431-009-0243-9
   Web of Science ®Google Scholar
• IDF Diabetes Atlas-Ninth edition (2019). https://www.diabetesatlas.org/upload/resources/2019/IDF_Atlas_9th_Edition_2019.pdf
   Google Scholar
• John, S., Thangapandian, S., Arooj, M., Hong, J. C., Kim, K. D., & Lee, K. W. (2011). Development, evaluation and application of 3D QSAR Pharmacophore model in the discovery of potential human renin inhibitors. BMC Bioinformatics, 12 (Suppl 14), S4. https://doi.org/10.1186/1471-2105-12-S14-S4
   Google Scholar
• Jude, K. M., Banerjee, A. L., Haldar, M. K., Manokaran, S., Roy, B., Mallik, S., Srivastava, D. K., & Christianson, D. W. (2006). Ultrahigh resolution crystal structures of human carbonic anhydrases I and II complexed with “two-prong” inhibitors reveal the molecular basis of high affinity. Journal of the American Chemical Society, 128(9), 3011–3018. https://doi.org/10.1021/ja057257n
   PubMed Web of Science ®Google Scholar
• Kamata, K., Mitsuya, M., Nishimura, T., Eiki, J. I., & Nagata, Y. (2004). Structural basis for allosteric regulation of the monomeric allosteric enzyme human glucokinase. Structure (London, England: 1993), 12(3), 429–438. https://doi.org/10.1016/j.str.2004.02.005
   PubMed Web of Science ®Google Scholar
• Kavitha, R., Karunagaran, S., Chandrabose, S. S., Lee, K. W., & Meganathan, C. (2015). Pharmacophore modeling, virtual screening, molecular docking studies and density functional theory approaches to identify novel ketohexokinase (KHK) inhibitors. Bio Systems, 138, 39–52. https://doi.org/10.1016/j.biosystems.2015.10.005
   PubMed Web of Science ®Google Scholar
• Khanal, P., Patil, B. M., Mandar, B. K., Dey, Y. N., & Duyu, T. (2019). Network pharmacology-based assessment to elucidate the molecular mechanism of anti-diabetic action of Tinospora cordifolia. Clinical Phytoscience, 5(1), 1–9. https://doi.org/10.1186/s40816-019-0131-1
   Google Scholar
• Kim, H. M., Park, B. S., Kim, J. I., Kim, S. E., Lee, J., Oh, S. C., Enkhbayar, P., Matsushima, N., Lee, H., Yoo, O. J., & Lee, J. O. (2007). Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist Eritoran. Cell, 130(5), 906–917. https://doi.org/10.1016/j.cell.2007.08.002
   PubMed Web of Science ®Google Scholar
• Klopfenstein, S. R., Evdokimov, A. G., Colson, A. O., Fairweather, N. T., Neuman, J. J., Maier, M. B., Gray, J. L., Gerwe, G. S., Stake, G. E., Howard, B. W., Farmer, J. A., Pokross, M. E., Downs, T. R., Kasibhatla, B., & Peters, K. G. (2006). 1,2,3,4-Tetrahydroisoquinolinyl sulfamic acids as phosphatase PTP1B inhibitors. Bioorganic & Medicinal Chemistry Letters, 16(6), 1574–1578. https://doi.org/10.1016/j.bmcl.2005.12.051
   PubMed Web of Science ®Google Scholar
• Lee, J. O., Yang, H., Georgescu, M. M., Cristofano, A. D., Maehama, T., Shi, Y., Dixon, J. E., Pandolfi, P., & Pavletich, N. P. (1999). Crystal structure of the PTEN tumor suppressor: Implications for its phosphoinositide phosphatase activity and membrane association. Cell, 99(3), 323–334. https://doi.org/10.1016/S0092-8674(00)81663-3
   PubMed Web of Science ®Google Scholar
• Li, W., Yuan, G., Pan, Y., Wang, C., & Chen, H. (2017). Network pharmacology studies on the bioactive compounds and action mechanisms of natural products for the treatment of diabetes mellitus: A review. Frontiers in Pharmacology, 8, 10–74. https://doi.org/10.3389/fphar.2017.00074
   PubMedGoogle Scholar
• Lin, J. H., & Yamazaki, M. (2003). Role of P-glycoprotein in pharmacokinetics: Clinical implications. Clinical Pharmacokinetics, 42(1), 59–98. https://doi.org/10.2165/00003088-200342010-00003
   PubMed Web of Science ®Google Scholar
• Mahanta, S., Chowdhury, P., Gogoi, N., Goswami, N., Borah, D., Kumar, R., Chetia, D., Borah, P., Buragohain, A. K., & Gogoi, B. (2020). Potential anti-viral activity of approved repurposed drug against main protease of SARS-CoV-2: An in silico based approach. Journal of Biomolecular Structure and Dynamics, 1–10. https://doi.org/10.1080/07391102.2020.1768902
   Web of Science ®Google Scholar
• Miller, B. R., Nguyen, H., Hu, C. J., Lin, C., & Nguyen, Q. T. (2014). New and emerging drugs and targets for type 2 diabetes. American Health & Drug Benefits, 7(8), 452-463. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4280522/pdf/ahdb-07-452.pdf
   Google Scholar
• Newman, D. J., & Cragg, G. M. (2012). Natural products as sources of new drugs over the 30 years from 1981 to 2010. Journal of Natural Products, 75(3), 311–335. https://doi.org/10.1021/np200906s
   PubMed Web of Science ®Google Scholar
• Niu, M., Dong, F., Tang, S., Fida, G., Qin, J., Qiu, J., Liu, K., Gao, W., & Gu, Y. (2013). Pharmacophore modeling and virtual screening for the discovery of new type 4 cAMP phosphodiesterase (PDE4) inhibitors. PLoS One, 8(12), e82360. https://doi.org/10.1371/journal.pone.0082360
   PubMed Web of Science ®Google Scholar
• Oyama, T., Toyota, K., Waku, T., Hirakawa, Y., Nagasawa, N., Kasuga, J. I., Hashimoto, Y., Miyachi, H., & Morikawa, K. (2009). Adaptability and selectivity of human peroxisome proliferator-activated receptor (PPAR) pan agonists revealed from crystal structures. Acta Crystallographica. Section D, Biological Crystallography, 65(Pt 8), 786–795. https://doi.org/10.1107/S0907444909015935
   PubMedGoogle Scholar
• Palleria, C., Di Paolo, A., Giofrè, C., Caglioti, C., Leuzzi, G., Siniscalchi, A., De Sarro, G., & Gallelli, L. (2013). Pharmacokinetic drug-drug interaction and their implication in clinical management. In Journal of Research in Medical Sciences, 18(7), 600–609.
   Web of Science ®Google Scholar
• Peters, J. U., Weber, S., Kritter, S., Weiss, P., Wallier, A., Boehringer, M., Hennig, M., Kuhn, B., & Loeffler, B. M. (2004). Aminomethylpyrimidines as novel DPP-IV inhibitors: A 10(5)-fold activity increase by optimization of aromatic substituents . Bioorganic & Medicinal Chemistry Letters, 14(6), 1491–1493. https://doi.org/10.1016/j.bmcl.2004.01.019
   PubMed Web of Science ®Google Scholar
• Pires, D. E. V., Blundell, T. L., & Ascher, D. B. (2015). pkCSM: Predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. Journal of Medicinal Chemistry, 58(9), 4066–4072. https://doi.org/10.1021/acs.jmedchem.5b00104
   PubMed Web of Science ®Google Scholar
• pkCSM. (n.d.). Retrieved August 5, (2020). from http://biosig.unimelb.edu.au/pkcsm/
   Google Scholar
• Ritchie, T. J., & Macdonald, S. J. F. (2009). The impact of aromatic ring count on compound developability—Are too many aromatic rings a liability in drug design?. Drug Discovery Today. , 14(21–22), 1011–1020. https://doi.org/10.1016/j.drudis.2009.07.014
   PubMed Web of Science ®Google Scholar
• Shannon, P., Markiel, A., Ozier, O., Baliga, N. S., Wang, J. T., Ramage, D., Amin, N., Schwikowski, B., & Ideker, T. (2003). Cytoscape: A software Environment for integrated models of biomolecular interaction networks. Genome Research, 13(11), 2498–2504. https://doi.org/10.1101/gr.1239303
   PubMed Web of Science ®Google Scholar
• Shiau, A. K., Barstad, D., Loria, P. M., Cheng, L., Kushner, P. J., Agard, D. A., & Greene, G. L. (1998). The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen. Cell, 95(7), 927–937. https://doi.org/10.1016/S0092-8674(00)81717-1 https://doi.org/10.1016/S0092-8674(00)81717-1
   PubMed Web of Science ®Google Scholar
• Shivanika, C., Deepak Kumar, S., Venkataraghavan Ragunathan, P., & Tiwari, S. A., B. D. P. (2020). Molecular docking, validation, dynamics simulations, and pharmacokinetic prediction of natural compounds against the SARS-CoV-2 main-protease. Journal of Biomolecular Structure and Dynamics, 1–27. https://doi.org/10.1080/07391102.2020.1815584
   Web of Science ®Google Scholar
• Sjöblom, M., Singh, A. K., Zheng, W., Wang, J., Tuo, B. G., Krabbenhöft, A., Riederer, B., Gros, G., & Seidler, U. (2009). Duodenal acidity “sensing” but not epithelial HCO3-supply is critically dependent on carbonic anhydrase II expression. Proceedings of the National Academy of Sciences of the United States of America, 106(31), 13094–13099. https://doi.org/10.1073/pnas.0901488106
   PubMed Web of Science ®Google Scholar
• Sun, D., Wang, Z., Caille, S., DeGraffenreid, M., Gonzalez-Lopez de Turiso, F., Hungate, R., Jaen, J. C., Jiang, B., Julian, L. D., Kelly, R., McMinn, D. L., Kaizerman, J., Rew, Y., Sudom, A., Tu, H., Ursu, S., Walker, N., Willcockson, M., Yan, X., Ye, Q., & Powers, J. P. (2011). Synthesis and optimization of novel 4,4-disubstituted cyclohexylbenzamide derivatives as potent 11β-HSD1 inhibitors. Bioorganic & Medicinal Chemistry Letters, 21(1), 405–410. https://doi.org/10.1016/j.bmcl.2010.10.129
   PubMed Web of Science ®Google Scholar
• Takahashi, N., Senda, M., Lin, S., Goto, T., Yano, M., Sasaki, T., Murakami, S., & Kawada, T. (2011). Auraptene regulates gene expression involved in lipid metabolism through PPARα activation in diabetic obese mice. Molecular Nutrition & Food Research, 55(12), 1791–1797. https://doi.org/10.1002/mnfr.201100401
   Google Scholar
• Tomioka, H. (2014). Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship). Current Pharmaceutical Design, 20(27), 4305–4306. https://doi.org/10.2174/1381612819666131118203915
   PubMed Web of Science ®Google Scholar
• Underwood, C. R., Garibay, P., Knudsen, L. B., Hastrup, S., Peters, G. H., Rudolph, R., & Reedtz-Runge, S. (2010). Crystal structure of glucagon-like peptide-1 in complex with the extracellular domain of the glucagon-like peptide-1 receptor. The Journal of Biological Chemistry, 285(1), 723–730. https://doi.org/10.1074/jbc.M109.033829
   PubMed Web of Science ®Google Scholar
• Williams, P. A., Cosme, J., Matak Vinković, D., Ward, A., Angove, H. C., Day, P. J., Vonrhein, C., Tickle, I. J., & Jhoti, H. (2004). Crystal structures of human cytochrome P450 3A4 bound to metyrapone and progesterone. Science (New York, N.Y.), 305(5684), 683–686. https://doi.org/10.1126/science.1099736
   PubMed Web of Science ®Google Scholar
• Wynn, R. M., Kato, M., Chuang, J. L., Tso, S. C., Li, J., & Chuang, D. T. (2008). Pyruvate dehydrogenase kinase-4 structures reveal a metastable open conformation fostering robust core-free basal activity. The Journal of Biological Chemistry, 283(37), 25305–25315. https://doi.org/10.1074/jbc.M802249200
   PubMed Web of Science ®Google Scholar
• Xiao, B., Heath, R., Saiu, P., Leiper, F. C., Leone, P., Jing, C., Walker, P. A., Haire, L., Eccleston, J. F., Davis, C. T., Martin, S. R., Carling, D., & Gamblin, S. J. (2007). Structural basis for AMP binding to mammalian AMP-activated protein kinase. Nature, 449(7161), 496–500. https://doi.org/10.1038/nature06161
   PubMed Web of Science ®Google Scholar
• Xu, Z. B., Chaudhary, D., Olland, S., Wolfrom, S., Czerwinski, R., Malakian, K., Lin, L., Stahl, M. L., Joseph-McCarthy, D., Benander, C., Fitz, L., Greco, R., Somers, W. S., & Mosyak, L. (2004). Catalytic domain crystal structure of protein kinase C-theta (PKCtheta). The Journal of Biological Chemistry, 279(48), 50401–50409. https://doi.org/10.1074/jbc.M409216200
   PubMed Web of Science ®Google Scholar
• Yazdanian, M., Glynn, S. L., Wright, J. L., & Hawi, A. (1998). Correlating partitioning and Caco-2 cell permeability of structurally diverse small molecular weight compounds. Pharmaceutical Research, 15(9), 1490–1494. https://doi.org/10.1023/A:1011930411574
   PubMed Web of Science ®Google Scholar
• Zheng, X., Zhang, L., Zhai, J., Chen, Y., Luo, H., & Hu, X. (2012). The molecular basis for inhibition of sulindac and its metabolites towards human aldose reductase. FEBS Letters, 586(1), 55–59. https://doi.org/10.1016/j.febslet.2011.11.023
   PubMed Web of Science ®Google Scholar
• Zheng, Y., Ley, S. H., & Hu, F. B. (2018). Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nature Reviews. Endocrinology, 14(2), 88–98. https://doi.org/10.1038/nrendo.2017.151
   PubMed Web of Science ®Google Scholar